Terlipressin versus albumin in the prevention of paracentesis associated adverse events in patients with cirrhosis and tense ascites. A multicenter randomised controlled trial.
Completed
- Conditions
- cirrhosis of the liver, ascites
- Registration Number
- NL-OMON23876
- Lead Sponsor
- Foundation for Liver Research (SLO)Erasmus MCc/o department of hepatology and gastroenterology,room Ca 326Dr. Molewaterplein 403015 GD Rotterdamtel (010) 463 5942
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 84
Inclusion Criteria
1. Cirrhosis with tense ascites requiring therapeutic paracentesis;
2. Age 18-70;
Exclusion Criteria
1. Hypertension treated with medication;
2. History of cardiac or coronary disease;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method